24 Week Open Label, Single Arm Study of Colesevelam in High Risk South Asians With Suboptimal LDL-c Levels Despite Maximally Tolerated Statin Therapy
Phase of Trial: Phase IV
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Colesevelam (Primary)
- Indications Coronary artery disease; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms CLASS-ACT
- 21 Jun 2016 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017.
- 21 Jun 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.
- 23 Jul 2015 New trial record